Pictet Group — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Azafaros is a clinical-stage biopharmaceutical company developing small-molecule therapies for severe rare genetic metabolic disorders, including GM1/GM2 gangliosidoses, Niemann-Pick type C disease, and other conditions.
BiotechDeep TechHealthtechMedical DevicesLeiden, NL
Hans Aerts(Professor)Hermen Overkleeft(Professor)Stan van Boeckel(Professor)
Co-investorsBioMedPartnersForbionJeito CapitalBioGeneration VenturesSeroba Life Sciences
Mainspring Energy develops power generation systems.
Deep TechEnergyHardware
Shannon Miller(Founder)in
BoardTom Linebarger(Chairman & Chief Executive Officer)
Co-investorsKhosla VenturesClearSkyDCVC (Data Collective)Fine Structures VenturesMarunouchi Innovation PartnersBreakthrough Energy Ventures+2 more
Unique provides a platform that accelerates business processes and go-to-market initiatives through generative AI applications and consulting expertise for enterprise clients.
AI & Machine LearningEnterprise SoftwareSaaSZurich, CH
Andreas Hauri(CTO/Founder)inManuel Grenacher(CEO/Founder)inMichelle Heppler(CCO/Co-Founder)in
Co-investorsDN CapitalKickstart InnovationVI PartnersCommerzVentures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.